BRIEF-Australia Gives Provisional Nod To J&J's COVID-19 Vaccine- Statement

1
1
Favorite

BRIEF-Australia Gives Provisional Nod To J&J's COVID-19 Vaccine- Statement

Reuters2021-06-25

June 25 (Reuters) -

* AUSTRALIA GRANTS PROVISIONAL APPROVAL TO J&J COVID-19 VACCINE - GOVERNMENT STATEMENT

* AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION APPROVES JNJ'S COVID-19 VACCINE IN ADULTS GREATER THAN OR EQUAL TO 18 YEARS OF AGE - STATEMENT

Source text Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

jeehek
·2021-06-25
gud
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2146074714?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-25 21:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2146074714","market":null,"top_or_hot":-1,"title":"BRIEF-Australia Gives Provisional Nod To J&J's COVID-19 Vaccine- Statement","media":"Reuters","content":"<html><body><p>June 25 (Reuters) - </p><p>   * AUSTRALIA GRANTS PROVISIONAL APPROVAL TO J&amp;J COVID-19 VACCINE - GOVERNMENT STATEMENT</p><p>   * AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION APPROVES JNJ'S COVID-19 VACCINE IN ADULTS GREATER THAN OR EQUAL TO 18 YEARS OF AGE - STATEMENT</p><p>Source text  Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Australia Gives Provisional Nod To J&J's COVID-19 Vaccine- Statement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Australia Gives Provisional Nod To J&J's COVID-19 Vaccine- Statement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 21:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>June 25 (Reuters) -    * AUSTRALIA GRANTS PROVISIONAL APPROVAL TO J&J COVID-19 VACCINE - GOVERNMENT STATEMENT   * AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION APPROVES JNJ'S COVID-19 VACCINE IN ADULTS...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2146074714","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2146074714","pubTimestamp":1624628793,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"June 25 (Reuters) -    * AUSTRALIA GRANTS PROVISIONAL APPROVAL TO J&J COVID-19 VACCINE - GOVERNMENT ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生"},"translate_title":"简报-澳大利亚临时认可J&J的新冠肺炎疫苗-声明","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":0.9},"content_text":"June 25 (Reuters) -    * AUSTRALIA GRANTS PROVISIONAL APPROVAL TO J&J COVID-19 VACCINE - GOVERNMENT STATEMENT   * AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION APPROVES JNJ'S COVID-19 VACCINE IN ADULTS GREATER THAN OR EQUAL TO 18 YEARS OF AGE - STATEMENTSource text  Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":122475418,"gmtCreate":1624631805934,"gmtModify":1703842310351,"author":{"id":"3585372326620783","authorId":"3585372326620783","name":"jeehek","avatar":"https://static.tigerbbs.com/c211de1bd9ce20decb682c9093c81314","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585372326620783","authorIdStr":"3585372326620783"},"htmlText":"gud","listText":"gud","text":"gud","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122475418","repostId":2146074714,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}